Sickle cell disease—the subject of a new Seminar in The Lancet—is one of the most prevalent and fastest-growing genetic disorders worldwide. Although its true prevalence is difficult to determine ...

Rare diseases are not actually that rare. Collectively they affect 500 million people around the world. Some, such as Huntington’s disease and sickle cell disease, affect many thousands, others only ...

On her best days, Tatyana Thompson’s pain was at a level five. Some days, it would stay that way, a persistent throb in her joints, her hands, her back. On other days, if she was dehydrated or was hit ...

Hemophilia usually is an inherited bleeding disorder in which the blood does not clot properly. Patients with severe hemophilia A may have to manage their condition with regular at-home injections or ...

Advances in sickle cell therapies, including gene editing, offer hope—but racial disparities, cost, and access barriers remain major challenges. Racial and ethnic disparities in health care persist in ...

PHILADELPHIA (KYW) -- A better treatment for sickle cell disease, which strikes mainly people of color, is transforming medicine in Philadelphia, making this Black History Month especially meaningful ...

A better treatment for sickle cell disease, which strikes mainly people of color, is transforming medicine in Philadelphia, making this Black History Month especially meaningful for one local family.

LOS ANGELES (KABC) -- For decades, treatments for lupus, which affects 1.5 million Americans, have been few and far between. The condition affects mainly women and can be debilitating. Now, a ...

This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free Morning Rounds newsletter here. Vertex executives warned that Casgevy, its ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...